Related Experiment Videos
Elevated growth hormone responses to pyridostigmine in obsessive-compulsive disorder: evidence of cholinergic
J V Lucey1, G Butcher, A W Clare
1Department of Psychiatry, Trinity College Medical School, St. James Hospital, Dublin, Ireland.
The American Journal of Psychiatry
|June 1, 1993
Abstract:
The growth hormone response to the acetylcholinesterase inhibitor pyridostigmine was measured in nine normothymic outpatients who met DSM-III-R criteria for obsessive-compulsive disorder. The responses were significantly elevated when compared to those found in a healthy comparison group (N = 9). The data suggest that cholinergic supersensitivity is present in obsessive-compulsive disorder.